Efficacy of CGS-1 in Migraine Female Volunteers: Randomized, Single-blind, Placebo-controlled, Crossover Trial
Not Applicable
- Conditions
- Migraine
- Registration Number
- JPRN-UMIN000028919
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Subjects with migraine with aura 2)Subjects with the headache without migraine 3)Subjects with taking triptan medicine. 4)Subjects with the hemicrania continua. 5)Subjects with pregnancies and lactations. 6)Subjects with atopic dermatitis. 7)Subjects with vulnerable to skin irritation by menthol or alcohol. 8)Subjects deemed inappropriate to participate in this study by the principle investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in NRS (Numerical Rating Scale) from the start of the test to 30 minutes later.
- Secondary Outcome Measures
Name Time Method 1)Change in NRS (Numerical Rating Scale) at 60 minutes, 120 minutes and 180 minutes after the start of the test. 2)Changes in daily disability assessment HIT (Headache Impact Test) - 6